FDA Drug recall D-1516-2020
Hydrochlorothiazide 50mg tablets, 14-count bags, Rx only, Distributed by: Calvin Scott & Co., Inc
- FDA Drug
- Class II
- terminated
- Published 2020-08-26
On 2020-08-26 the FDA classified a Class II recall of Hydrochlorothiazide 50mg tablets, 14-count bags, Rx only, Distributed by: Calvin Scott & Co., Inc by Calvin Scott And, citing CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1516-2020 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2020-07-27 |
| Published | 2020-08-26 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Calvin Scott And |
| Distribution | US |
Product
Hydrochlorothiazide 50mg tablets, 14-count bags, Rx only, Distributed by: Calvin Scott & Co., Inc. Albuquerque, NM 87123, Manufactured by Accord Healthcare, Inc., Durham NC 27703; NDC 16729-0184-17
Reason
CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.
Identifiers
| code_info | Lot #: 18252, 19033, Exp. Date: 10/20 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1516-2020%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.